ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 917

$564K Total Retail Price of All Prescriptions

Rank: 85 out of 917

321 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,140 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 641 626 1 5
ALENDRONATE SODIUM 579 568 2 23
OMEPRAZOLE 488 437 3 4
METFORMIN HCL 475 407 4 8
GLIPIZIDE 459 437 5 40
SIMVASTATIN 396 348 6 2
LISINOPRIL 366 299 7 1
ATORVASTATIN CALCIUM 363 351 8 14
METOPROLOL TARTRATE 350 334 9 11
ATENOLOL 312 281 10 12
CRESTOR 289 253 11 30
LOSARTAN POTASSIUM 277 271 12 13
HYDROCHLOROTHIAZIDE 239 216 13 9
NEXIUM 226 202 14 60
DIOVAN 206 195 15 49
RANITIDINE HCL 182 160 16 29
LIPITOR 176 167 17 89
FLUTICASONE PROPIONATE 175 142 18 26
LIDODERM 173 157 19 64
TAMSULOSIN HCL 167 136 20 25
TRICOR 152 137 21 163
LEVOTHYROXINE SODIUM 140 89 22 3
CALCITONIN-SALMON 139 126 23 209
FENOFIBRATE 125 98 24 73
CLOPIDOGREL 111 102 25 50
CLOBETASOL PROPIONATE 109 102 26 203
TRAMADOL HCL 107 101 27 28
LOPERAMIDE 107 94 27 243
ZETIA 100 71 29 93
PATANOL 93 90 30 212
JANUVIA 91 91 31 81
TRIAMTERENE-HCTZ 90 90 32 36
PLAVIX 78 74 33 84
ALLOPURINOL 77 64 34 31
AZITHROMYCIN 75 63 35 61
LOVASTATIN 73 71 36 19
TRIAMCINOLONE ACETONIDE 67 58 37 96
ISOSORBIDE MONONITRATE ER 64 62 38 70
PRAVASTATIN SODIUM 64 51 38 20
KETOCONAZOLE 61 50 40 185
LEVOFLOXACIN 60 54 41 138
ADVAIR DISKUS 58 58 42 47
NIFEDIPINE ER 56 56 43 139
LACTULOSE 53 23 44 133
GABAPENTIN 51 34 45 17
SINGULAIR 50 50 46 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.